165 / 180
321
34. Salama H, Zekri AR, Medhat E, Al Alim SA, Ahmed OS, Bahnassy
AA, et al. Peripheral vein infusion of autologous mesenchymal
stem cells in Egyptian HCV-positive patients with end-stage
liver disease. Stem Cell Res Ther 2014; 5:70.
35. Spahr L, Chalandon Y, Terraz S, Kindler V, Rubbia-Brandt L,
Frossard JL, et al. Autologous bone marrow mononuclear cell
transplantation in patients with decompensated alcoholic
liver disease: a randomized controlled trial. PLoS One 2013;
8:e53719.
36. Higashiyama R, Inagaki Y, Hong YY, Kushida M, Nakao S,
Niioka M, et al. Bone Marrow-Derived Cells Express Matrix
Metalloproteinases and Contribute to Regression of Liver
Fibrosis in Mice. Hepatology 2007; 45:213-22.
37. Baertschiger RM, Serre-Beinier V, Morel P, Bosco D, Peyrou M,
Clément S, et al. Fibrogenic Potential of Human Multipotent
Mesenchymal Stromal Cells in Injured liver. PLoS One 2009;
4:e6657.
38. Houlihan DD, Newsome PN. Critical review of clinical trials of
bone marrow stem cells in liver disease. Gastroenterology 2008;
135:438-50.
39. Pan Q, Fouraschen SM, de Ruiter PE, Dinjens WN, Kwekkeboom
J, Tilanus HW, van der Laan LJ. Detection of spontaneous
tumorigenic transformation during culture expansion of human
mesenchymal stromal cells. Exp Biol Med 2014; 239:105-15).
[CÉLULAS MADRE: FUNDAMENTOS Y REVISIÓN DE LA EXPERIENCIA CLÍNICA EN ENFERMEDADES HEPÁTICAS - Dra. Daniela Fluxá y col.]